Stockscreener 앱 받기
5.85
25.90%
1.12
전일 마감가:
$4.73
열려 있는:
$4.9
하루 거래량:
338.14K
Relative Volume:
0.66
시가총액:
$2.26M
수익:
$32.31M
순이익/손실:
$-6.16M
주가수익비율:
-3.4412
EPS:
-1.7
순현금흐름:
$1.08M
1주 성능:
+0.08%
1개월 성능:
+72.61%
6개월 성능:
-96.47%
1년 성능:
-99.54%
1일 변동 폭
$4.60
$6.39
1주일 범위
$4.01
$6.39
52주 변동 폭
$2.51
$2,592.00
유니버스 파마슈티컬스 Stock (UPC) Company Profile
명칭
Universe Pharmaceuticals Inc
전화
-
주소
-
UPC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
UPC
Universe Pharmaceuticals Inc
|
5.925 | 2.26M | 32.31M | -6.16M | 1.08M | -1.70 |
|
ZTS
Zoetis Inc
|
157.71 | 68.50B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.35 | 47.71B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.62 | 46.12B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.45 | 18.55B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
295.83 | 13.40B | 2.76B | 1.11B | 898.10M | 22.77 |
유니버스 파마슈티컬스 주식(UPC)의 최신 뉴스
Universe Pharmaceuticals Reports Full Year 2024 Earnings - Yahoo Finance
Universe Pharmaceuticals INC (UPC) Stock: A Year of Highs and Lows - investchronicle.com
Bitfarms Ltd [BITF] Revenue clocked in at $192.88 million, down -31.54% YTD: What’s Next? - dbtnews.com
Universe Pharmaceuticals INC [UPC] Is Currently 41.67 below its 200 Period Moving Avg: What Does This Mean? - dbtnews.com
Power & Digital Infrastructure Acquisition (OTCMKTS:XPDIU) Stock Price Up 1.8% – Should You Buy? - Defense World
Universe Pharmaceuticals (NYSE:UPC) Shares Up 10.5% – Here’s Why - Defense World
Universe Pharmaceuticals INC (UPC) Stock: Uncovering 52-Week Market Trends - investchronicle.com
Pre-market Movers: RGC, SYRS, ADTX, ATXI... - RTTNews
UPC’s Stock Dilemma: Universe Pharmaceuticals INC’s Market Performance and Outlook - investchronicle.com
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Universe Pharmaceuticals stock plunges to 52-week low of $3.20 - Investing.com
Pre-market Movers: RGLS, SLNO, OCEA, OSRH... - RTTNews
Pre-market Movers: PTPI, ACON, HUMA, TNON... - RTTNews
Pre-market Movers: TNON, POAI, MURA, BSGM... - RTTNews
Upcoming Stock Splits This Week (March 24 to March 28) – Stay Invested - markets.businessinsider.com
Universe Pharmaceuticals stock plunges to 52-week low of $0.08 By Investing.com - Investing.com Australia
Universe Pharmaceuticals stock plunges to 52-week low of $0.08 - Investing.com
Universe Pharmaceuticals Announces Share Consolidation - TipRanks
Universe Pharmaceuticals Plans To Effect Share ConsolidationQuick Facts - Nasdaq
Universe Pharmaceuticals INC Announces Share Consolidation Effective March 24, 2025 - Nasdaq
NewtekOne, Inc. Closes Private Offering of Senior Unsecured Notes - The Manila Times
Universe Pharmaceuticals INC Announces Share Consolidation - GlobeNewswire
Major Shake-up: Universe Pharmaceuticals Announces 40:1 Share ConsolidationWhat It Means For Investors - StockTitan
Universe Pharmaceuticals stock plunges to 52-week low of $0.1 By Investing.com - Investing.com South Africa
Universe Pharmaceuticals stock plunges to 52-week low of $0.1 - Investing.com India
Universe Pharmaceuticals (NYSE:UPC) Trading Down 4.3% – What’s Next? - Defense World
Pre-market Movers: HCTI, HEPA, ZYXI, SYRS ... - RTTNews
Universe Pharmaceuticals Approves Share Consolidation at Extraordinary Meeting - TipRanks
UPC’s price-to-book ratio: An indicator of the company’s performance - US Post News
Universe Pharmaceuticals Adjourns Shareholder Meeting Due to Lack of Quorum - TipRanks
Universe Pharmaceuticals stock plunges to 52-week low of $0.14 - Investing.com India
Universe Pharmaceuticals stock plunges to 52-week low of $0.14 By Investing.com - Investing.com South Africa
Universe Pharmaceuticals receives notice from Nasdaq related to delayed annual report - MSN
Universe Pharmaceuticals faces potential Nasdaq delisting By Investing.com - Investing.com India
Universe Pharmaceuticals INC Receives Staff Determination Notice from Nasdaq Related to Delayed Annual Report - The Manila Times
Universe Pharmaceuticals Faces Nasdaq Delisting Risk Due to Delayed Annual Report - TipRanks
Universe Pharmaceuticals faces potential Nasdaq delisting - Investing.com
Universe Pharmaceuticals INC Faces Potential Delisting from Nasdaq Due to Delinquent Annual Report Filing - Nasdaq
Will Universe Pharmaceuticals Survive Nasdaq's Latest Delisting Threat? - StockTitan
Looking Into Universe Pharmaceuticals's Recent Short Interest - Benzinga
Promising Chinese Stocks Worth Watching – February 21st - Defense World
Dow Tumbles Over 700 Points; US Services PMI Falls In February - Benzinga
유니버스 파마슈티컬스 (UPC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.77%
0.87%
자본화:
|
볼륨(24시간):